A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

Discover BioNTech SE's innovative RNA lipoplex patent, detailing advanced methods for stable RNA delivery, GMP production, and effective intravenous administration.

RNAConnect, a pioneering life science reagent company, today announced new distribution agreements with CliniSciences, 2BScientific, and Dakewe Biotech. These partnerships mark a significant milestone ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...

“A cell type is a group of cells that are similar to each other and distinct from other groups of cells,” offers ...

Goldman Sachs has initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) based on multi-blockbuster, first-to-market ...

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each ...

Discover Curevac NV's groundbreaking patent for an mRNA-based vaccine targeting prostate cancer. Learn how it stimulates immune responses against multiple antigens.

Professor Julius Lucks’s device leverages advances in in vitro synthetic biology to diagnose disease in crops before the ...

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond th ...